At a glance
ClinicalIndex Comparison RecordN/ACompleted· 331 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patient-reported-outcomes(PROs) in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin in Primary Care Settings
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted Oct 24, 2014·Updated Feb 3, 2021
In Brief
An observational study evaluating No intervention for Low-Back Pain. Completed, enrolled 331 participants across 33 sites.
Detailed Summary
The purpose of this study is to evaluate the effect of pregabalin comparing with the conventional analgesic care in chronic low back pain patients with accompanying lower limb pain (neuropathic component) treated in primary care settings under routine clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLow-Back Pain
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJul 2014
First PostedOct 2014
Primary CompletionFeb 2015
Study CompletionMar 2015
TodayJul 2026
First PostedOct 24, 2014
Enrollment StartJul 1, 2014
Primary CompletionFeb 1, 2015
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.7 years ago
Interventions
No interventionother
The study is observational